![PRESENTED BY:
ARJUMAND NAVEERA
PHARMD [PB].
SULTAN –UL-ULOOM COLLEGE OF PHARMACY
Guided by:
Dr. S P Srinivas Nayak, Assistant Professor, SUCP, Hyd.
3/5/2021
ARJUMAND, SUCP](https://image.slidesharecdn.com/sulfonylureasarjumand-210305132921/85/Sulfonyl-ureas-pharmacology-Presented-by-arjumand-1-320.jpg)

![Sulfonylureas are most commonly used Oral
Hypoglycemic drugs helpful in treating Diabetes
Mellitus .
They show their effects on beta cells of the pancreas
to release insulin which maintains the blood sugar
level.
They are also called as ATP sensitive Potassium[K]
channel blockers.
3/5/2021
ARJUMAND, SUCP](https://image.slidesharecdn.com/sulfonylureasarjumand-210305132921/85/Sulfonyl-ureas-pharmacology-Presented-by-arjumand-3-320.jpg)





![• Text book of PHARMACOLOGY – KD TRIPATHI
• Clinical Pharmacy and Therapeutics [ 3 Edition ] – ROGER
WALKER
• Wikipedia
• Text book of PHARMACOLOGY [ 2 Edition ] – JAGDISH
PRASAD
3/5/2021
ARJUMAND, SUCP](https://image.slidesharecdn.com/sulfonylureasarjumand-210305132921/85/Sulfonyl-ureas-pharmacology-Presented-by-arjumand-9-320.jpg)

The document discusses sulfonylureas, commonly used oral hypoglycemic drugs for treating diabetes mellitus, which enhance insulin release from pancreatic beta cells. It details their mechanism of action, side effects like low blood sugar and weight gain, and interactions with other drugs. The presentation also lists first and second-generation sulfonylureas and cites sources for further reference.
![PRESENTED BY:
ARJUMAND NAVEERA
PHARMD [PB].
SULTAN –UL-ULOOM COLLEGE OF PHARMACY
Guided by:
Dr. S P Srinivas Nayak, Assistant Professor, SUCP, Hyd.
3/5/2021
ARJUMAND, SUCP](https://image.slidesharecdn.com/sulfonylureasarjumand-210305132921/85/Sulfonyl-ureas-pharmacology-Presented-by-arjumand-1-320.jpg)

![Sulfonylureas are most commonly used Oral
Hypoglycemic drugs helpful in treating Diabetes
Mellitus .
They show their effects on beta cells of the pancreas
to release insulin which maintains the blood sugar
level.
They are also called as ATP sensitive Potassium[K]
channel blockers.
3/5/2021
ARJUMAND, SUCP](https://image.slidesharecdn.com/sulfonylureasarjumand-210305132921/85/Sulfonyl-ureas-pharmacology-Presented-by-arjumand-3-320.jpg)





![• Text book of PHARMACOLOGY – KD TRIPATHI
• Clinical Pharmacy and Therapeutics [ 3 Edition ] – ROGER
WALKER
• Wikipedia
• Text book of PHARMACOLOGY [ 2 Edition ] – JAGDISH
PRASAD
3/5/2021
ARJUMAND, SUCP](https://image.slidesharecdn.com/sulfonylureasarjumand-210305132921/85/Sulfonyl-ureas-pharmacology-Presented-by-arjumand-9-320.jpg)
